[1]
SHAHZADI, A. et al. 2025. EFFECT OF HIGH VERSUS LOW ROSUVASTATIN THERAPY ON 12-WEEK MORTALITY AND LEFT VENTRICULAR CARDIAC FUNCTION IN PATIENTS SUFFERING FROM FIRST ST SEGMENT ELEVATION MI. Annals of Pakistan Medical & Allied Professionals. 1, 5, August (Aug. 2025), 20–27. DOI:https://doi.org/10.53350/Annalspakmed.1.5.20.